
NTUS
Healthcare · Health Care Equipment & Supplies · $1.14B market cap
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Jun 30, 2022
EPS trend, 90 days to now · 0.0% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| May 5, 2022 | After the close | 0.26 | 0.22 | -15.4% |
| Feb 24, 2022 | After the close | 0.44 | 0.47 | +6.8% |
| Nov 4, 2021 | After the close | 0.34 | 0.28 | -17.6% |
| Aug 5, 2021 | After the close | 0.25 | 0.29 | +16.0% |
| May 6, 2021 | After the close | 0.16 | 0.16 | 0.0% |
| Feb 25, 2021 | After the close | 0.24 | 0.39 | +62.5% |
| Oct 29, 2020 | After the close | 0.01 | 0.09 | +800.0% |
| Jul 30, 2020 | After the close | 0.05 | -0.13 | -360.0% |
| Apr 30, 2020 | After the close | 0.22 | 0.04 | -81.8% |
| Feb 6, 2020 | After the close | 0.47 | 0.46 | -2.1% |
| Oct 24, 2019 | After the close | 0.38 | 0.36 | -5.3% |
| Jul 25, 2019 | After the close | 0.30 | 0.34 | +13.3% |
| Apr 25, 2019 | After the close | 0.06 | 0.09 |
Natus Medical Incorporated provides medical device solutions focuses on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide. It offers products and technologies used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disorders, and…
| +50.0% |
| Feb 13, 2019 | Before the open | 0.50 | 0.43 | -14.0% |
| Oct 24, 2018 | Before the open | 0.42 | 0.40 | -4.8% |
| Jul 25, 2018 | Before the open | 0.26 | 0.35 | +34.6% |
| Apr 25, 2018 | Before the open | 0.24 | 0.24 | 0.0% |
| Feb 7, 2018 | Before the open | 0.54 | 0.42 | -22.2% |